Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
Clinical trial NCT05082974 · COMPLETED
Trial details
- NCT number
- NCT05082974
- Sponsor
- Vance Thompson Vision ND
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2022-08-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.